In a study by George and colleagues using gene expression and copy number analysis in a cohort with high-grade serous ovarian cancer, tumors with BRCA1 alterations harbored significantly increased intra-epithelial T-cell infiltration compared to BRCA2-mutated samples [56]. The gene discussed is BRCA1; the disease is ovarian serous adenocarcinoma.